Preoperative aspirin and anticoagulants do not affect partial nephrectomy bleeding.

IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Canadian Journal of Urology Pub Date : 2024-04-01
Muqsit Buchh, Courtney Yong, Fezaan Kazi, Ali Sualeh, James Slaven, Ronald S Boris, Chandru P Sundaram
{"title":"Preoperative aspirin and anticoagulants do not affect partial nephrectomy bleeding.","authors":"Muqsit Buchh, Courtney Yong, Fezaan Kazi, Ali Sualeh, James Slaven, Ronald S Boris, Chandru P Sundaram","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Studies have reached mixed conclusions on the role of antiplatelet and anticoagulant agents on postoperative complications of partial nephrectomies. This study examines whether preoperative anticoagulation use affected the risk of hemorrhagic complications after partial nephrectomy.</p><p><strong>Materials and methods: </strong>This is a retrospective chart review of all partial nephrectomies performed between 2017 and 2022 at a single institution. For each operation, preoperative data was gathered on whether the patient was on anticoagulation, the type and dose of anticoagulation, and how many days the anticoagulation was held preoperatively. Bivariate analyses for continuous measures were performed using Student's t-tests when there were two comparison groups and ANOVA models when there were more than two comparison groups and Chi-Square tests were used for categorical variables, with Fisher's Exact being used when expected cell counts were small.</p><p><strong>Results: </strong>In this study, warfarin was held for an average of 5.43 days, clopidogrel was held for an average of 6.60 days, aspirin was held for an average of 7.65 days, and direct oral anticoagulants (DOACs) were held for an average of 4.00 days. There was no significant difference in hemoglobin (Hb) change, rate of intraoperative transfusion, postoperative transfusion, bleeding complication, pseudoaneurysm rate, or additional bleeding processes between patients on prior anticoagulation therapy and those not on therapy. There was no significant difference in intraoperative or postoperative outcomes based on history of aspirin use and continuation of aspirin through the surgery. While estimated blood loss appeared statistically significant initially, this difference was accounted for by the covariates of comorbidities, RENAL score, surgical approach, and type of renorrhaphy. Overall, there was no difference in complication rate based solely on aspirin use or continuation of aspirin through surgery.</p><p><strong>Conclusions: </strong>No difference in complication rate of partial nephrectomy was determined to be solely due to prior use of anticoagulation or aspirin use alone with appropriate cessation of anticoagulation preoperatively. Overall, patients on anticoagulation are not at a higher risk of intraoperative or postoperative bleeding complications when undergoing partial nephrectomy.</p>","PeriodicalId":56323,"journal":{"name":"Canadian Journal of Urology","volume":"31 2","pages":"11834-11839"},"PeriodicalIF":1.2000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Studies have reached mixed conclusions on the role of antiplatelet and anticoagulant agents on postoperative complications of partial nephrectomies. This study examines whether preoperative anticoagulation use affected the risk of hemorrhagic complications after partial nephrectomy.

Materials and methods: This is a retrospective chart review of all partial nephrectomies performed between 2017 and 2022 at a single institution. For each operation, preoperative data was gathered on whether the patient was on anticoagulation, the type and dose of anticoagulation, and how many days the anticoagulation was held preoperatively. Bivariate analyses for continuous measures were performed using Student's t-tests when there were two comparison groups and ANOVA models when there were more than two comparison groups and Chi-Square tests were used for categorical variables, with Fisher's Exact being used when expected cell counts were small.

Results: In this study, warfarin was held for an average of 5.43 days, clopidogrel was held for an average of 6.60 days, aspirin was held for an average of 7.65 days, and direct oral anticoagulants (DOACs) were held for an average of 4.00 days. There was no significant difference in hemoglobin (Hb) change, rate of intraoperative transfusion, postoperative transfusion, bleeding complication, pseudoaneurysm rate, or additional bleeding processes between patients on prior anticoagulation therapy and those not on therapy. There was no significant difference in intraoperative or postoperative outcomes based on history of aspirin use and continuation of aspirin through the surgery. While estimated blood loss appeared statistically significant initially, this difference was accounted for by the covariates of comorbidities, RENAL score, surgical approach, and type of renorrhaphy. Overall, there was no difference in complication rate based solely on aspirin use or continuation of aspirin through surgery.

Conclusions: No difference in complication rate of partial nephrectomy was determined to be solely due to prior use of anticoagulation or aspirin use alone with appropriate cessation of anticoagulation preoperatively. Overall, patients on anticoagulation are not at a higher risk of intraoperative or postoperative bleeding complications when undergoing partial nephrectomy.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
术前服用阿司匹林和抗凝剂不会影响肾部分切除术出血。
导言:关于抗血小板和抗凝剂对肾部分切除术术后并发症的作用,研究结论不一。本研究探讨了术前使用抗凝药物是否会影响肾部分切除术后出血并发症的风险:这是一项回顾性病历审查,涉及一家机构在 2017 年至 2022 年期间实施的所有肾部分切除术。对于每例手术,均收集了患者术前是否接受抗凝治疗、抗凝治疗的类型和剂量以及术前抗凝治疗的天数等数据。连续变量的双变量分析在有两个比较组时使用学生 t 检验,在有两个以上比较组时使用方差分析模型,分类变量使用 Chi-Square 检验,在预期细胞数较少时使用费雪精确检验:在这项研究中,华法林的平均滞留时间为 5.43 天,氯吡格雷的平均滞留时间为 6.60 天,阿司匹林的平均滞留时间为 7.65 天,直接口服抗凝药(DOACs)的平均滞留时间为 4.00 天。在血红蛋白(Hb)变化、术中输血率、术后输血率、出血并发症、假性动脉瘤发生率或其他出血过程方面,接受过抗凝治疗的患者与未接受抗凝治疗的患者没有明显差异。根据阿司匹林使用史和手术期间是否继续服用阿司匹林,术中或术后结果没有明显差异。虽然最初估计的失血量具有统计学意义,但合并症、RENAL 评分、手术方法和肾造瘘术类型等协变量可解释这种差异。总体而言,仅根据使用阿司匹林或手术期间继续使用阿司匹林,并发症发生率没有差异:结论:肾部分切除术的并发症发生率不会仅因术前使用抗凝药或术前适当停止使用阿司匹林而产生差异。总体而言,接受肾部分切除术的抗凝患者术中或术后出血并发症的风险并不高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Canadian Journal of Urology
Canadian Journal of Urology UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
86
审稿时长
6-12 weeks
期刊介绍: The CJU publishes articles of interest to the field of urology and related specialties who treat urologic diseases.
期刊最新文献
Single-port robotic laparoscopic ureterocalicostomy: surgical technique and clinical outcomes. Clinical implications of tumor laterality in renal cell carcinoma. Hypogonadism, frailty, and postoperative outcomes among men undergoing partial nephrectomy. Illuminating the use of photodynamic therapy in urologic oncology. Legends in Urology v31I06.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1